about
Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trialsMelatonin as a Potential Agent in the Treatment of SarcopeniaVitamin E in sarcopenia: current evidences on its role in prevention and treatmentSarcopenia in older adultsBody mass index from age 15 years onwards and muscle mass, strength, and quality in early old age: findings from the MRC National Survey of Health and Development.The pleiotropic effect of physical exercise on mitochondrial dynamics in aging skeletal muscle.Relationship of anabolic and catabolic biomarkers with muscle strength and physical performance in older adults: a population-based cross-sectional studyInteraction between bone and muscle in older persons with mobility limitationsAging, physical activity, and disease prevention 2012.Skeletal muscle: an endocrine organ.Association between Sarcopenia, Bone Density, and Health-Related Quality of Life in Korean Men.Identification of biological markers for better characterization of older subjects with physical frailty and sarcopenia.Biomolecular basis of the role of diabetes mellitus in osteoporosis and bone fracturesClinical practice guidelines on postmenopausal osteoporosis: An executive summary and recommendationsAssociation of the K153R polymorphism in the myostatin gene and extreme longevity.Physical activity is medicine for older adults.Effect of diet-induced weight loss on muscle strength in adults with overweight or obesity - a systematic review and meta-analysis of clinical trials.Pathogenesis and Management of Sarcopenia.Hindlimb Immobilization, But Not Castration, Induces Reduction of Undercarboxylated Osteocalcin Associated With Muscle Atrophy in Rats.Compensatory anabolic signaling in the sarcopenia of experimental chronic arthritis.Biochemical Pathways of Sarcopenia and Their Modulation by Physical Exercise: A Narrative Review.TGFβ Superfamily Members Mediate Androgen Deprivation Therapy-Induced Obese Frailty in Male Mice.Protein thiol oxidation does not change in skeletal muscles of aging female mice.Association of cognitive impairment, depressive symptoms and sarcopenia among healthy older men in the veterans retirement community in southern Taiwan: a cross-sectional study.Insulin resistance: a risk marker for disease and disability in the older person.2D:4D digit ratio is associated with cognitive decline but not frailty in community-dwelling older adults.Reconsideration of frailty in relation to surgical indication.Reference values for handgrip strength in young people of both sexes.Population-based study of age- and sex-related differences in muscle density and size in thoracic and lumbar spine: the Framingham study.Sarcopenia: assessment of disease burden and strategies to improve outcomes.Dysphagia risk, low muscle strength and poor cognition predict malnutrition risk in older adults athospital admission.Decreased muscle mass is not an independent risk factor for metabolic syndrome in Korean population aged 70 or older
P2860
Q27022354-DCE25237-01CA-4A86-A583-55E5AB16DF43Q28076649-C239924F-DC5E-4A4B-A5C4-64FCBEF9A29AQ28390862-84E02564-15C1-400E-895D-EB15BF4D29DEQ33789846-B7132E76-AE94-4EFB-B851-A7EA9D79A367Q34152628-AA23372A-9B8D-4D35-822E-B11728585996Q35471306-712C73C1-99BA-4C4E-A3CA-311311911F96Q35749690-B53CFEE4-2792-4E9A-B209-CAC7A1640E6FQ36100758-782346EA-1519-4EB7-BCEA-95370E6D66D3Q36470368-E972596A-8EB3-4AAC-80D2-E155694D6AD6Q37008029-0CF3EB15-A861-49C9-9A49-DA2517408971Q37054174-065F8CCC-B48A-4F62-9E28-00145FD6A2F4Q37074556-28C06919-6004-4DEC-81E4-BFFEAABA76AEQ37101614-F4D8AC0C-CE72-4508-84D0-A1F02D49B25FQ37202400-35A4A504-DB1D-4725-BA88-7B8406D5F563Q37300631-FFFB340D-41E0-438D-A141-D7C73D105A00Q37465422-DB6238E5-CA42-4CE2-B729-9672A9EBE555Q38820298-252861AE-4544-4BF3-A4A9-2F8308EF1BA0Q39019596-361CC3DE-9909-43B4-A0A5-4B657E871B92Q39690195-004C3AB6-2B03-42D1-B9C0-0689D2FBCDA5Q40109875-033D84C2-40BD-43D2-AA88-F8F22A081A13Q42372844-74E6939A-8C9D-4705-BAA8-CD5FF3C24929Q43095052-FC3C078B-8C2A-4310-8870-7EA2E554BC3EQ43590360-99CF56AC-E085-400D-AC2C-BA4CDBC815BFQ45329105-2027E540-C8B2-4891-BABF-2EDE6D08340EQ45330314-C17F096F-929B-4B62-ADE0-969332A20A41Q47759052-99D0B423-DEC1-4D7C-8BBD-60FC6702BDA1Q47820539-3C114BCF-D080-45A7-8072-80562696C02DQ50931531-E0441AC7-791F-4A1F-B8C8-535A8C4CF8BCQ51760749-B7D48FA7-1441-4AE5-A2EC-8E3C7A2CEA5AQ55022891-FD21C1A2-B896-4913-9AA2-4061AF3345FAQ55385105-8F3066FD-3BA2-4A72-B298-6A5FBA3BD858Q57221311-707DA0E4-DA5A-4906-B50B-235DB43EBB99
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Sarcopenia and age-related endocrine function
@ast
Sarcopenia and age-related endocrine function
@en
Sarcopenia and age-related endocrine function
@en-gb
Sarcopenia and age-related endocrine function
@nl
type
label
Sarcopenia and age-related endocrine function
@ast
Sarcopenia and age-related endocrine function
@en
Sarcopenia and age-related endocrine function
@en-gb
Sarcopenia and age-related endocrine function
@nl
altLabel
Sarcopenia and Age-Related Endocrine Function
@en
prefLabel
Sarcopenia and age-related endocrine function
@ast
Sarcopenia and age-related endocrine function
@en
Sarcopenia and age-related endocrine function
@en-gb
Sarcopenia and age-related endocrine function
@nl
P2860
P3181
P356
P1476
Sarcopenia and age-related endocrine function
@en
P2093
Akihiko Yamaguchi
P2860
P304
P3181
P356
10.1155/2012/127362
P407
P577
2012-01-01T00:00:00Z